XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.62+0.08 (+5.19%)
Close on Nov 17, 2026Market cap $15.33MP/E –Yield –
XTL Biopharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$1.03M. The highest annual figure on record is -$707.00K in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.03M | – |
| FY2024 | Dec 31, 2024 | -$1.62M | – |
| FY2023 | Dec 31, 2023 | -$707.00K | – |
| FY2022 | Dec 31, 2022 | -$901.00K | – |
| FY2021 | Dec 31, 2021 | -$1.05M | – |
| FY2020 | Dec 31, 2020 | -$850.00K | – |
| FY2019 | Dec 31, 2019 | -$908.00K | – |
| FY2018 | Dec 31, 2018 | -$816.00K | – |
| FY2017 | Dec 31, 2017 | -$1.13M | – |
| FY2016 | Dec 31, 2016 | -$1.73M | – |
| FY2015 | Dec 31, 2015 | -$1.86M | – |
See a number that looks wrong?